Status:
COMPLETED
Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Healthy
Eligibility:
MALE
20-35 years
Phase:
PHASE1
Brief Summary
Evaluation whether Brotizolam is absorbed through the mucous membrane of oral cavity when WE 941 OD tablets are administered in Japanese healthy male volunteers.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy male volunteers
- age 20 - 35 years
- body weight 50 - 80 kg
- Body Mass Index (BMI) +/- 20%
Exclusion
Key Trial Info
Start Date :
March 1 2000
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT02218671
Start Date
March 1 2000
Last Update
August 18 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.